Clinical researchCoronary artery diseaseHealth-related quality of life after interventional or conservative strategy in patients with unstable angina or non–ST-segment elevation myocardial infarction: One-year results of the third randomized intervention trial of unstable angina (RITA-3)
Coronary artery disease
Under an Elsevier user license
open archive
Abbreviations and acronyms
ACS
acute coronary syndrome
CS
conservative strategy
CCS
Canadian Cardiovascular Society
HRQOL
health-related quality of life
IS
interventional strategy
EQ-5D
EuroQOL 5-Dimensional Classification
EQ-VAS
EuroQOL Visual Analogue Scale
MI
myocardial infarction
RITA-3
third Randomized Intervention Trial of unstable Angina
SAQ
Seattle Angina Questionnaire
SF-36
Short Form-36
Cited by (0)
RITA-3 was funded by a competitive grant from the British Heart Foundation (London), and the British Heart Foundation received a donation from Aventis Pharma (Strasbourg, France). Additional governmental support (Culyer) was obtained to partially reimburse interventional center costs of percutaneous coronary intervention catheters and stents. The authors have no conflicts of interest with respect to the RITA-3 trial. However, Dr. Henderson has received honoraria from Schering Plough, as well as travel grants from Boston Scientific and Medtronic AVE. Dr. Fox or his institution has received unrestricted grant funding and/or honoraria from Bristol Myers Squibb, Sanofi-Synthelabo, Aventis, Merck, and Bayer.
Copyright © 2005 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.